Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 24
2003 22
2004 21
2005 31
2006 15
2007 27
2008 23
2009 26
2010 25
2011 36
2012 29
2013 40
2014 33
2015 46
2016 38
2017 37
2018 31
2019 19
2020 24
2021 18
2022 21
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

527 results

Results by year

Filters applied: . Clear all
Page 1
Age-associated CD4+ T cells with B cell-promoting functions are regulated by ZEB2 in autoimmunity.
Goto M, Takahashi H, Yoshida R, Itamiya T, Nakano M, Nagafuchi Y, Harada H, Shimizu T, Maeda M, Kubota A, Toda T, Hatano H, Sugimori Y, Kawahata K, Yamamoto K, Shoda H, Ishigaki K, Ota M, Okamura T, Fujio K. Goto M, et al. Among authors: yamamoto k. Sci Immunol. 2024 Mar 29;9(93):eadk1643. doi: 10.1126/sciimmunol.adk1643. Epub 2024 Mar 29. Sci Immunol. 2024. PMID: 38330141
Improved quantitative analysis of tenuifolin using hydrolytic continuous-flow system to build prediction models for its content based on near-infrared spectroscopy.
Kitazoe T, Usui C, Kodaira E, Maruyama T, Kawano N, Fuchino H, Yamamoto K, Kitano Y, Kawahara N, Yoshimatsu K, Shirahata T, Kobayashi Y. Kitazoe T, et al. Among authors: yamamoto k. J Nat Med. 2024 Mar;78(2):296-311. doi: 10.1007/s11418-023-01764-0. Epub 2024 Jan 4. J Nat Med. 2024. PMID: 38172356
Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease.
Ono C, Tanaka S, Myouzen K, Iwasaki T, Ueda M, Oda Y, Yamamoto K, Kochi Y, Baba Y. Ono C, et al. Among authors: yamamoto k. Front Immunol. 2023 Sep 28;14:1276014. doi: 10.3389/fimmu.2023.1276014. eCollection 2023. Front Immunol. 2023. PMID: 37841260 Free PMC article.
Cepharanthine and Oral Lichen Planus Efficacy (COLE) study: protocol for a multicentre randomised controlled study assessing the efficacy and safety of cepharanthine with topical corticosteroids in oral lichen planus.
Yagyuu T, Isogawa M, Yamamoto K, Sugiura T, Matsusue Y, Kasahara M, Kirita T. Yagyuu T, et al. Among authors: yamamoto k. BMJ Open. 2023 Aug 16;13(8):e074279. doi: 10.1136/bmjopen-2023-074279. BMJ Open. 2023. PMID: 37586860 Free PMC article.
Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.
Urata T, Naoi Y, Jiang A, Boyle M, Sunami K, Imai T, Nawa Y, Hiramatsu Y, Yamamoto K, Fujii S, Yoshida I, Yano T, Chijimatsu R, Murakami H, Ikeuchi K, Kobayashi H, Tani K, Ujiie H, Inoue H, Tomida S, Yamamoto A, Kondo T, Fujiwara H, Asada N, Nishimori H, Fujii K, Fujii N, Matsuoka KI, Sawada K, Momose S, Tamaru JI, Nishikori A, Sato Y, Yoshino T, Maeda Y, Scott DW, Ennishi D. Urata T, et al. Among authors: yamamoto k. Blood Adv. 2023 Dec 26;7(24):7459-7470. doi: 10.1182/bloodadvances.2023010402. Blood Adv. 2023. PMID: 37552496 Free PMC article.
Multimodal repertoire analysis unveils B cell biology in immune-mediated diseases.
Ota M, Nakano M, Nagafuchi Y, Kobayashi S, Hatano H, Yoshida R, Akutsu Y, Itamiya T, Ban N, Tsuchida Y, Shoda H, Yamamoto K, Ishigaki K, Okamura T, Fujio K. Ota M, et al. Among authors: yamamoto k. Ann Rheum Dis. 2023 Nov;82(11):1455-1463. doi: 10.1136/ard-2023-224421. Epub 2023 Jul 19. Ann Rheum Dis. 2023. PMID: 37468219
527 results